STOCK TITAN

Envista Holdings Corporation - NVST STOCK NEWS

Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.

Envista Holdings Corporation (NYSE: NVST) is a leading global dental products company committed to empowering dental professionals worldwide. Headquartered in Brea, California, Envista develops, manufactures, and markets an extensive portfolio of dental consumables, equipment, and services. The company operates through two primary segments: Specialty Products & Technologies and Equipment & Consumables.

The Specialty Products & Technologies segment focuses on dental implant systems, regenerative solutions, dental prosthetics, orthodontic systems, and lab products. This segment is dedicated to advancing the capabilities of dental professionals through innovative products and technologies.

The Equipment & Consumables segment offers a broad range of dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, supporting the diagnostic, treatment, and prevention needs of dental conditions.

Envista has a strong commitment to continuous improvement, action-oriented innovation, and a deep respect for dental professionals. Its comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs, ensuring a holistic approach to dental care.

Recent achievements include the launch of the DEXIS digital ecosystem, an AI-powered platform designed to streamline implant dentistry workflows. This interconnected system combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning, empowering clinicians to manage implant cases efficiently.

Envista continues to innovate with products like the ORTHOPANTOMOGRAPH™ OP 3D™ LX, which enhances 3D diagnostic capabilities, and the IS ScanFlow software, which integrates AI-driven tools to maximize productivity in dental practices.

Financially, Envista reported sales of $623.6 million for the first quarter of 2024, with core sales growth and ongoing investments aimed at accelerating growth and profitability. The company has a proven track record of resilience and strategic differentiation, particularly through the challenges posed by the global pandemic and other economic factors.

Envista's philanthropic arm, the Envista Smile Project, exemplifies its commitment to social responsibility. The project has donated millions to improve access to oral health for underserved communities, partnering with institutions like the University of Southern California to enhance dental care for vulnerable populations.

Envista's significant market positions in attractive dental segments, coupled with its continuous improvement culture and innovation-driven approach, make it a pivotal player in the dental industry. For more information, visit the official website at www.envistaco.com.

Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will announce its Q1 2021 financial results on May 5, 2021, followed by a conference call at 2:00 PM PT. The call will last approximately an hour and will be accessible through Envista's website. A replay will be available post-presentation. Envista, a prominent player in the dental products sector, offers over 30 brands and addresses about 90% of dentists' needs. The company emphasizes its commitment to innovation and customer focus in delivering quality patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.43%
Tags
-
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) announced a four-year contract extension with Heartland Dental, the largest dental support organization in the U.S. This partnership solidifies Envista's role as a major supplier of dental products such as implants and imaging technology. Since their partnership began in 2016, Heartland Dental has accessed Envista's extensive product portfolio, enhancing care for over 1,800 supported dentists. This extension underscores Envista's commitment to quality and support within the dental industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.62%
Tags
partnership
-
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) reported robust financial results for Q4 2020, with a net income of $108.4 million, translating to $0.64 per diluted share. Adjusted net income stood at $94.6 million, or $0.56 per diluted share. Notably, adjusted EBITDA grew by 23.1% to $150.8 million, and sales rose by 1.6% year-over-year to $732.3 million. Core sales increased by 3.4%, while operating cash flow also saw a rise of 3.4% to $193.4 million. The company repaid $472 million in bank term debt and aims for enhanced performance in 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.16%
Tags
none
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will report its fourth quarter 2020 financial results on February 10, 2021, followed by a conference call at 2:00 PM PT. The call will be accessible via phone and webcast on Envista's website. The company, known for its extensive range of dental products, aims to help professionals enhance patient care. Envista partners with leading dental brands to address 90% of dentists' clinical needs, covering diagnostics and treatment options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.52%
Tags
-
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will participate in the JP Morgan Healthcare Conference on January 11, 2021, at 4:30 PM ET. Investors can access the event via Envista's Investor Relations website. Envista is a leading global dental products company, offering a comprehensive portfolio that covers approximately 90% of dentists' clinical needs. Since separating from Danaher Corporation in 2019, Envista has established a strong market position through its commitment to innovation and customer-focused solutions. For more information, visit www.envistaco.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.19%
Tags
none
-
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) reported its Q3 2020 financial results, showing a net income of $35.6 million, or $0.22 per share. Adjusted net income was $77.9 million, translating to $0.48 per diluted share. Sales fell by 2.9% year-over-year to $640.5 million, but sequential sales improved by 76.9% from Q2 2020. Adjusted EBITDA rose by 18.6% to $131.9 million. Free cash flow surged 70.3% to $134.9 million. The CEO highlighted significant recovery in the dental market and the impact of strategic initiatives on growth and margin.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.98%
Tags
none
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will announce third quarter financial results on October 29, 2020, followed by a conference call at 2:00 PM PT. The call will be accessible via the company's website, where both the earnings press release and an accompanying slide presentation will be available. Envista, which emerged as an independent company in 2019, serves the dental industry with a robust portfolio of brands and solutions. The company focuses on improving patient care through innovative dental products and technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
-
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will participate in two upcoming healthcare conferences. The first is the Baird 2020 Global Healthcare Conference on September 9, 2020, where CEO Amir Aghdaei will present from 10:50 to 11:20 AM ET. The second event, the Morgan Stanley 18th Annual Global Healthcare Conference, is scheduled for September 16, 2020, with Aghdaei presenting from 4:15 to 4:45 PM ET. Investors can access these presentations on Envista's Investor Relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
none
-
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) reported a net loss of $93.5 million, or $0.59 per share, for Q2 2020, marking a 49.2% decline in sales year-over-year to $362.0 million. Core sales dropped 46.2%, attributable to the COVID-19 pandemic impacts. Despite the losses, the company noted a sequential improvement in sales each month. Cost reduction measures exceeded $100 million, including workforce adjustments. Although no guidance for 2020 was provided due to uncertainties, management expressed optimism regarding recovery in the dental market and ongoing restructuring efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.19%
Tags
none
Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will announce its second-quarter 2020 financial results on July 30, 2020. The results will be discussed in a conference call starting at 2:00 PM PT, with a duration of approximately one hour. Interested parties can access the call by dialing 866-648-5306 (U.S.) or +1 602-563-8479 (international) with conference ID # 1571434. A replay will be available until August 13, 2020. Investors can view the earnings press release and related materials on the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.91%
Tags

FAQ

What is the current stock price of Envista Holdings Corporation (NVST)?

The current stock price of Envista Holdings Corporation (NVST) is $21.05 as of January 22, 2025.

What is the market cap of Envista Holdings Corporation (NVST)?

The market cap of Envista Holdings Corporation (NVST) is approximately 3.6B.

What does Envista Holdings Corporation do?

Envista Holdings Corporation develops, manufactures, and markets dental consumables, equipment, and services to dental professionals worldwide.

What are the main segments of Envista's business?

Envista operates through two primary segments: Specialty Products & Technologies, and Equipment & Consumables.

What recent achievements has Envista made?

Recently, Envista launched the DEXIS digital ecosystem, an AI-powered platform for implant dentistry, and the ORTHOPANTOMOGRAPH™ OP 3D™ LX for enhanced 3D diagnostics.

How did Envista perform financially in the first quarter of 2024?

Envista reported sales of $623.6 million, with a net income of $23.6 million or $0.14 per diluted share for the first quarter of 2024.

What is the Envista Smile Project?

The Envista Smile Project is a philanthropic foundation aimed at improving oral health for disadvantaged communities through donations and medical mission trips.

Who is the new CEO of Envista Holdings Corporation?

Paul Keel was appointed as the new CEO of Envista Holdings Corporation effective May 1, 2024.

How does Envista support dental professionals?

Envista supports dental professionals by providing a comprehensive portfolio of dental consumables, solutions, technology, and services.

What is the DEXIS digital ecosystem?

The DEXIS digital ecosystem is an interconnected, AI-powered platform designed to streamline and manage the implant dentistry workflow.

What is the Envista Business System (EBS)?

The Envista Business System (EBS) is a methodology that underpins the company's operations, focusing on continuous improvement and innovation.

Where can I find more information about Envista Holdings Corporation?

For more information, please visit Envista's official website at www.envistaco.com.
Envista Holdings Corporation

NYSE:NVST

NVST Rankings

NVST Stock Data

3.58B
170.69M
0.79%
114.37%
6.52%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States of America
BREA